Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy

PURPOSE: For precision medicine, exploration and monitoring of molecular biomarkers are essential. However, in advanced gastric cancer (GC) with visceral lesions, an invasive procedure cannot be performed repeatedly for the follow-up of molecular biomarkers. MATERIALS AND METHODS: To verify the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seung-Hyun, Lee, Choong-kun, Kwon, Woo Sun, Yun, Sujin, Jung, Minkyu, Kim, Hyo Song, Chung, Hyun Cheol, Chung, Yeun-Jun, Rha, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462813/
https://www.ncbi.nlm.nih.gov/pubmed/37634629
http://dx.doi.org/10.3349/ymj.2023.0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462813/
https://www.ncbi.nlm.nih.gov/pubmed/37634629
http://dx.doi.org/10.3349/ymj.2023.0096

Ejemplares similares